tirzepatide weight loss expected leads to reduction in people with obesity due to MC4R deficiency New drug tirzepatide delivers significant

How important is lifestyle modification when using these medications for weight management

Nausea or stomach discomfort While not everyone experiences nausea, it often appears alongside diarrhoea during the early titration phase

Following the aforementioned incidents, the development of lotiglipron was discontinued, and drug regulatory agencies in several countries classified GLP-1RAs as a potential risk factor for thyroid cancer, gallbladder, and biliary diseases

Clinical studies suggest that tirzepatide (found in Mounjaro and Zepbound) may lead to greater weight loss on average because it mimics two hormones (GLP-1 and GIP) instead of just one